Company intelligence / Profile preview

BioRay Pharmaceutical Co., Ltd.

Shanghai, Shanghai, Chinabioray.com ↗

Ownership: Private
Development stage: Commercial

Overview

BioRay is a commercial-stage biopharmaceutical company based in China focused on discovering, developing, manufacturing, and commercializing novel antibody therapeutics for immune-mediated diseases and cancers. Its lead program is an ADC targeting ROR1-positive hematological malignancies and solid tumors using its proprietary CysX™ platform. The company also has marketed products and end-to-end capabilities from R&D to manufacturing. The Taiwan-based affiliate focuses on probiotics, immune cell products, health supplements, precision diagnostics/lab services, but does not appear to have late-stage drug assets.

Therapeutic areas: Oncology
Modalities: Monoclonal antibodiesAntibody-drug conjugates (ADCs)Probiotics and medicinal fungi
Industry: Biotech

Drug pipeline

12 assets

anbainuo

11 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on BioRay Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioRay Pharmaceutical Co., Ltd..

Explore the full profile